Patoloxía Molecular das Doenzas Raras
PatMol-DR
![Foto de Patoloxía Molecular das Doenzas Raras](/img/grupo.png)
![Foto de University of Cambridge](/img/noimage_org.png)
University of Cambridge
Cambridge, Reino UnidoPublicacións en colaboración con investigadores/as de University of Cambridge (6)
2022
2020
-
European lipodystrophy registry: Background and structure
Orphanet Journal of Rare Diseases, Vol. 15, Núm. 1
-
α-Synuclein strains target distinct brain regions and cell types
Nature Neuroscience, Vol. 23, Núm. 1, pp. 21-31
2019
-
Long-term effectiveness and safety of metreleptin in the treatment of patients with partial lipodystrophy
Endocrine, Vol. 64, Núm. 3, pp. 500-511
2018
-
Long-term effectiveness and safety of metreleptin in the treatment of patients with generalized lipodystrophy
Endocrine, Vol. 60, Núm. 3, pp. 479-489
2016
-
The diagnosis and management of lipodystrophy syndromes: A multi-society practice guideline
Journal of Clinical Endocrinology and Metabolism, Vol. 101, Núm. 12, pp. 4500-4511